Abstract
Typhoid fever, a systemic infection caused by Salmonella enterica serotype typhi, remains an important worldwide cause of morbidity and mortality. Endemic cases in the United States are unusual, with most following foreign travel to the Indian subcontinent, Africa, Asia, or Latin America. The classic findings of typhoid fever include rose spots, relative bradycardia, and stepwise fevers, but unfortunately these signs are frequently absent. Gastrointestinal manifestations may include diffuse abdominal pain, bleeding, perforation, cholecystitis, and cholangitis. The diagnosis should be suspected after collection of the appropriate clinical and travel history with confirmation by blood or bone marrow culture. Novel methods are in development to establish the diagnosis when cultures are negative or unavailable. Multidrug resistance has increased worldwide, and decisions on antimicrobial therapy must take such resistance into account. The empiric treatment of choice is a fluoroquinolone drug; ceftriaxone and azithromycin are alternatives. Preventive strategies include good sanitation and food handling practices along with vaccination of selected groups.
Similar content being viewed by others
References and Recommended Reading
Case records of the Massachusetts General Hospital: Weekly clinicopathological exercises. Case 22-2001. N Engl J Med 2001, 345:201–205. This case presentation of a traveler who returned to the United States reviews the clinical features, pathogenesis, and treatment of typhoid fever
Smith T: The hog-cholera group of bacteria. US Bur Anim Ind Bull 1894, 6:6–40.
Sanderson KE, Roth JR: Linkage map of Salmonella typhimurium, edition VII. Microbiol Rev 1988, 52:485–532.
Popoff MY, Bockemuhl J, Hickman-Brenner FW: Supplement 1995 (no. 39) to the Kauffmann-White scheme. Res Microbiol 1996, 147:765–769.
Gray PW, Flaggs G, Leong SR, et al.: Cloning of the cDNA of a human neutrophil bactericidal protein: structural and functional correlations. J Biol Chem 1989, 264:9505–9509.
Edelman R, Levine MM: Summary of an international workshop on typhoid fever. Rev Infect Dis 1986, 8:329–349.
Ryan CA, Hargrett-Bean NT, Blake PA: Salmonella typhi infections in the United States, 1975–1984: increasing role of foreign travel. Rev Infect Dis 1989, 11:1–8.
Mermin JH, Townes JM, Gerber M, et al.: Typhoid fever in the United States, 1985–1994: changing risks of international travel and increasing antimicrobial resistance. Arch Intern Med 1998, 158:633–638. A review of 2445 cases of typhoid fever in the United States showing that most cases have occurred in young people traveling to endemic areas, particularly the Indian subcontinent. This paper also demonstrates the rising resistance to antimicrobial agents over the 10-year period of the study.
O’Brien D, Tobin S, Brown GV, et al.: Fever in returned travelers: review of hospital admissions for a 3-year period. Clin Infect Dis 2002, 33:603–609.
Crump JA, Griffin PM, Angulo FJ: Bacterial contamination of animal feed and its relationship to human foodborne illness. Clin Infect Dis 2002, 35:859–865. This review highlights the importance of a safe food supply with an emphasis on preventing contamination of animal feed. The authors review various gastrointestinal infections, including S. typhi, that may occur with contamination.
National Communicable Disease Center: Salmonella Surveillance Report. Washington, DC: NCDC; 1967. Report No. 63.
Torin DE, Betts SL, McClenahan JB, et al.: A typhoid fever outbreak on a university campus. Arch Intern Med 1969, 124:606–610.
Mallory A, Belden EA, Brachman PS: The current status of typhoid fever in the United States and a description of an outbreak. J Infect Dis 1969, 119:673–676.
Hoffman TA, Ruiz CJ, Counts GW, et al.: Waterborne typhoid fever in Dade County, Florida: clinical and therapeutic evaluation of 105 bacteremic patients. Am J Med 1975, 59:481–487.
Blaser MJ, Rafuse EM, Wells JG, et al.: An outbreak of salmonellosis involving multiple vehicles. Am J Epidemiol 1981, 114:663–670.
Taylor JP, Shandera WX, Betz TG, et al.: Typhoid fever in San Antonio, Texas: an outbreak traced to a continuing source. J Infect Dis 1984, 149:553–557.
Engleberg NC, Barrett TJ, Fisher H, et al.: Identification of a carrier by using Vi enzyme-linked immunosorbent assay serology in an outbreak of typhoid fever on an Indian reservation. J Clin Microbiol 1983, 18:1320–1322.
Lin FYC, Becke JM, Groves C: Restaurant-associated outbreak of typhoid fever in Maryland: identification of carrier facilitated by measurement of serum Vi antibodies. J Clin Microbiol 1988, 26:1194–1197.
Birkhead GS, Morse DL, Levine WC, et al.: Typhoid fever at a resort hotel in New York: a large outbreak with an unusual vehicle. J Infect Dis 1993, 167:1228–1232.
Typhoid fever: Skagit County, Washington. MMWR Morb Mortal Wkly Rep 1990, 39:749–751.
Cote TR, Convrey H, Robinson D, et al.: Typhoid fever in the park: epidemiology of an outbreak at a cultural interface. J Commun Health 1995, 20:451–458.
Katz DJ, Cruz MA, Trepka MJ, et al.: An outbreak of typhoid fever in Florida associated with an imported frozen fruit. J Infect Dis 2002, 186:234–239. An epidemiologic investigation of the most recent US outbreak of typhoid fever involving 15 patients with identical genomic profiles, which were acquired by ingestion of contaminated tropical fruit.
Pradier C, Keita-Perse O, Bernard E, et al.: Outbreak of typhoid fever on the French Riviera. Eur J Clin Microbiol Infect Dis 2000, 19:464–467.
Outbreak of quinolone-resistant, multiresistant Salmonella typhimurium DT104, Denmark. WHO Wkly Epidemiol Rec 1998, 73:190–191.
Dunstan SJ, Stephens HA, Blackwell JM, et al.: Genes of the class II and class III major histocompatibility complex are associated with typhoid fever in Vietnam. J Infect Dis 2001, 183:261–268.
Barrett-Conner E: Bacterial infection and sickle cell anemia: an analysis of 250 infections in 166 patients and a review of the literature. Medicine 1971, 50:97–112.
Neves J, Raso P, Marinko PP: Prolonged septicemic salmonellosis intercurrent with Schistosomiasis mansoni infection. J Trop Med Hyg 1971, 74:9.
Black PH, Kunz KL, Swartz MN: Salmonellosis: a review of some unusual aspects. N Engl J Med 1960, 262:864–870, 921–927.
Celum CL, Chaisson RE, Rutherford GW, et al.: Incidence of salmonellosis in patients with AIDS. J Infect Dis 1987, 156:998–1002.
Waddell WR, Kunz LJ: Association of Salmonella enteritidis with operation of stomach. N Engl J Med 1956, 255:555–559.
Spika JS, Waterman SH, Hoo GW, et al.: Chloramphenicolresistant Salmonella newport traced through hamburger to dairy farms: a major persisting source of human salmonellosis in California. N Engl J Med 1987, 316:565–570.
Weikel CS, Guerrant RL: Nosocomial salmonellosis [editorial]. Infect Control 1985, 6:218–220.
House D, Bishop A, Parry C, et al.: Typhoid fever: pathogenesis and disease. Curr Opin Infect Dis 2001, 14:573–578. A review of the pathogenesis of S. typhi, including sections on the invasion of gastrointestinal epithelial cells, dissemination to systemic sites, and the ability of the organism to survive within host cells.
Naylor GRE: Incubation period and other features of foodborne and water-borne outbreaks of typhoid fever in relation to pathogenesis and genetics of resistance. Lancet 1983, 1:864–866.
Hornick RB, Greisman SE, Woodward TE, et al.: Typhoid fever: pathogenesis and immunologic control. N Engl J Med 1970, 283:686–691.
Blaser MJ, Newman LS: A review of human salmonellosis: I. Infective dose. Rev Infect Dis 1982, 4:1096–1106.
Mintz ED, Cartter ML, Madler JL, et al.: Dose-response effects in an outbreak of Salmonella enteritidis. Epidemiol Infect 1994, 112:13–23.
Everest P, Wain J, Roberts M, et al.: The molecular mechanisms of severe typhoid fever. Trends Microbiol 2001, 9:316–320.
Lee TP, Hoffman SL: Typhoid fever. In Hunter’s Tropical Medicine and Emerging Infectious Diseases, edn 8. Edited by Hunter GW. Philadelphia: WB Saunders Co.; 2000:471–484.
Stephens I, Levine NM: Management of typhoid fever in children. Pediatr Infect Dis J 2002, 21:157–158. A summary of the overall management of pediatric typhoid fever. A section on antibiotic therapy discusses global antibiotic resistance patterns and gives guidelines on which agent to use in various countries.
Stuart BM, Pullen RL: Typhoid: clinical analysis of three hundred and sixty cases. Arch Intern Med 1946, 78:629–661.
Davis TM, Makepeace AE, Dallimore EA, et al.: Relative bradycardia is not a feature of enteric fever in children. Clin Infect Dis 1999, 28:582–586.
Zuckerman MJ, Meza AD, Ho H, et al.: Lower gastrointestinal bleed in a patient with typhoid fever. Am J Gastroenterol 2000, 95:843–845.
Stoner MC, Forsythe R, Mills AS, et al.: Intestinal perforation secondary to Salmonella typhi: case report and review of the literature. Am Surg 2000, 66:219–222.
Lambotte O, Debord T, Castagne C, et al.: Unusual presentation of typhoid fever: cutaneous vasculitis, pancreatitis, and splenic abscess. J Infect 2001, 42:161–162.
Kadappu KK, Rao PV, Srinivas N, et al.: Pancreatitis in enteric fever. Indian J Gastroenterol 2002, 21:32–33.
Khan M, Coovadia Y, Connolly C, et al.: Risk factors predicting complications in blood culture-proven typhoid fever in adults. Scand J Infect Dis 2000, 32:201–205.
Alsoub H, Uwaydah AK, Matar I, et al.: A clinical comparison of typhoid fever caused by susceptible and multidrug-resistant strains of Salmonella typhi. Br J Clin Pract 1997, 51:8–10.
Haefeli WE, Ott R, Bircher AJ, et al.: Hair loss following typhoid fever: a forgotten phenomenon. Clin Infect Dis 1995, 20:723–4.
Brooks J: The sad and tragic life of Typhoid Mary. CMAJ 1996, 154:915–916.
Shukla VK, Singh H, Pandey M, et al.: Carcinoma of the gallbladder: Is it a sequel of typhoid? Dig Dis Sci 2000, 45:900–903.
Dutta U, Garg PK, Kumar R, et al.: Typhoid carriers among patients with gallstones are at increased risk for carcinoma of the gallbladder. Am J Gastroenterol 2000, 95:784–787.
Caygill CP, Hill MJ, Braddick M, et al.: Cancer mortality in chronic typhoid and paratyphoid carriers. Lancet 1994, 343:83–84.
Gasem MH, Dolmans WM, Isbandrio BB, et al.: Culture of Salmonella typhi and Salmonella paratyphi from blood and bone marrow in suspected typhoid fever. Trop Geogr Med 1995, 47:164–167.
Chart H, Cheesbrough JS, Waghorn DJ: The serodiagnosis of infection with Salmonella typhi. J Clin Pathol 2000, 53:851–853.
House D, Wain J, Ho VA, et al.: Serology of typhoid fever in an area of endemicity and its relevance to diagnosis. J Clin Microbiol 2001, 39:1002–1007.
Hatta M, Goris MG, Heerkens E, et al.: Simple dipstick assay for the detection of Salmonella typhi-specific IgM antibodies and the evolution of the immune response in patients with typhoid fever. Am J Trop Med Hyg 2002, 66:416–421.
Gasem MH, Smits HL, Goris MG, et al.: Evaluation of a simple and rapid dipstick assay for the diagnosis of typhoid fever. J Med Microbiol 2002, 51:173–177.
Haque A, Ahmed N, Peerzada A, et al.: Utility of PCR in the diagnosis of problematic cases of typhoid. Jpn J Infect Dis 2001, 54:237–239.
Kamath PS, Jalihal A, Chakraborty A: Differentiation of typhoid fever from fulminant hepatic failure in patients presenting with jaundice and encephalopathy. Mayo Clin Proc 2000, 75:462–466.
Akalin HE: Quinolones in the treatment of typhoid fever. Drugs 1999, 58:52–54. A concise review of the use of fluoroquinolones in enteric fever with sections on the treatment of multidrug-resistant S. typhi and quinolone use in children.
Hien TT, Bethell DB, Hoa NTT, et al.: Short course of ofloxacin for treatment of multidrug-resistant typhoid. Clin Infect Dis 1995, 20:917–923.
Wain J, Hoa NT, Chinh NT, et al.: Quinolone-resistant Salmonella typhi in Viet Nam: molecular basis of resistance and clinical response to treatment. Clin Infect Dis 1997, 25:1404–1410.
Vinh H, Wain J, Hanh VTN, et al.: Two or three days of ofloxacin treatment for uncomplicated multidrug-resistant typhoid fever in children. Antimicrob Agents Chemother 1996, 40:958–961.
Cao XT, Kneen R, Nguyen TA, et al.: A comparative study of ofloxacin and cefixime for treatment of typhoid fever in children. Pediatr Infect Dis J, 1999; 18:245–248.
Bhutta ZA, Khan IA, Shadmani M: Failure of short-course ceftriaxone chemotherapy for multidrug-resistant typhoid fever in children: a randomized controlled trial in Pakistan. Antimicrob Agents Chemother 2000, 44:450–452.
Wallace MR, Yousif AA, Mahroos GA, et al.: Ciprofloxacin versus ceftriaxone in the treatment of multidrug resistant typhoid fever. Eur J Clin Microbiol Infect Dis 1993, 12:907–910.
Doherty CP, Saha SK, Cutting WAM: Typhoid fever, ciprofloxacin and growth in young children. Ann Trop Paediatr 2000, 20:297–303.
Thomsen LL, Paerregaard A: Treatment with ciprofloxacin in children with typhoid fever. Scand Infect Dis J 1998, 30:355–357.
Butler T, Sridhar CB, Daga MK, et al.: Treatment of typhoid fever with azithromycin versus chloramphenicol in a randomized multicentre trial in India. J Antimicrob Chemother 1999, 44:243–250.
Girgis NI, Butler T, Frenck RW, et al.: Azithromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with multidrug resistance. Antimicrob Agents Chemother 1999, 43:1441–1444.
Frenck RW, Nakhla I, Sultan Y, et al.: Azithromycin versus ceftriaxone for the treatment of uncomplicated typhoid fever in children. Clin Infect Dis 2000, 31:1134–1138.
Wallace MR, Yousif AA, Habib NF, et al.: Azithromycin and typhoid. Lancet 1994, 343:1497–1498.
Farid Z, Girgis NI, Kamal M, et al.: Successful aztreonam treatment of acute typhoid fever after chloramphenicol failure. Scand J Infect Dis 1990, 22:505–506.
Tanaka-Kido J, Ortega L, Santos JI: Comparative efficacies of aztreonam and chloramphenicol in children with typhoid fever. Pediatr Infect Dis J 1990, 9:44–48.
Choo KE, Ariffin WA, Ong KH, et al.: Aztreonam failure in typhoid fever. Lancet 1991, 337:498.
Cherubin CE, Eng RH, Smith SM, et al.: Cephalosporin therapy for salmonellosis: questions of efficacy and cross resistance with ampicillin. Arch Intern Med 1986, 146:2149–2152.
Vaudaux P, Waldvogel FA: Gentamicin antibacterial activity in the presence of human polymorphonuclear leukocytes. Antimicrob Agents Chemother 1979, 16:743–749.
Hoffman SL, Punjabi NH, Kumala S, et al.: Reduction of mortality in chloramphenicol-treated severe typhoid fever by high-dose dexamethasone. N Engl J Med 1984, 310:82–88.
Ackers M-L, Puhr ND, Tauxe RV, et al.: Laboratory-based surveillance of Salmonella serotype typhi infections in the United States: antimicrobial resistance on the rise. JAMA 2000, 283:2668–2673. Up-to-date surveillance of the S. typhi isolates within the United States with respect to epidemiologic data and antimicrobial resistance patterns. This study clearly demonstrates that ciprofloxacin or ceftriaxone are appropriate therapy for S. typhi isolates in the United States; however, this may change in the future as suggested by the 7% nalidixic acid resistance.
Rowe B, Ward LR, Threlfall EJ: Multidrug-resistant Salmonella typhi: a worldwide epidemic. Clin Infect Dis 1997, 24:S106-S019. A nice review explaining the increasing antimicrobial resistance worldwide with a table showing global outbreaks caused by multresistant S. typhi.
Gupta A, Swarnkar NK, Choudhary SP: Changing antibiotic sensitivity in enteric fever. J Trop Pediatr 2001, 47:369–371.
Rodrigues C, Mehta A, Joshi VR: Salmonella typhi in the past decade: learning to live with resistance. Clin Infect Dis 2002, 34:126.
Threlfall EJ, Ward LR: Decreased susceptibility to ciprofloxacin in Salmonella enterica serotype typhi, United Kingdom. Emerg Infect Dis 2001, 7:448–450.
Ahmad K: Experts call for surveillance of drug-resistant typhoid at a global level. Lancet 2002, 359:592.
Ferreccio C, Morris JG, Valdivieso C, et al.: Efficacy of ciprofloxacin in the treatment of chronic typhoid carriers. J Infect Dis 1988, 157:1235–1239.
Carmeli Y, Raz R, Schapiro JM, et al.: Typhoid fever in Ethiopian immigrants to Israel and native-born Israelis: a comparative study. Clin Infect Dis 1993, 16:213–215.
Butler T, Islam A, Kabir I, et al.: Patterns of morbidity and mortality in typhoid fever dependent of age and gender: review of 552 hospitalized patients with diarrhea. Rev Infect Dis 1991, 13:85–90.
Yang HH, Kigore PE, Yang LH, et al.: An outbreak of typhoid fever, Xing-An County, People’s Republic of China, 1999: estimation of the field effectiveness of Vi polysaccharide typhoid vaccine. J Infect Dis 2001, 183:1775–1780.
Ying F, Ho VA, Khiem HB, et al.: The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children. N Engl J Med 2001, 344:1263–1269.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Crum, N.F. Current trends in typhoid fever. Curr Gastroenterol Rep 5, 279–286 (2003). https://doi.org/10.1007/s11894-003-0064-0
Issue Date:
DOI: https://doi.org/10.1007/s11894-003-0064-0